About: COVID-19: Emergence, Spread, Possible Treatments, and Global Burden

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19: Emergence, Spread, Possible Treatments, and Global Burden Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
Creator	Alexander, A Keni, R Mudgal, J Nandakumar, K Nayak, P
Source	Medline; PMC
abstract	The Coronavirus (CoV) is a large family of viruses known to cause illnesses ranging from the common cold to acute respiratory tract infection. The severity of the infection may be visible as pneumonia, acute respiratory syndrome, and even death. Until the outbreak of SARS, this group of viruses was greatly overlooked. However, since the SARS and MERS outbreaks, these viruses have been studied in greater detail, propelling the vaccine research. On December 31, 2019, mysterious cases of pneumonia were detected in the city of Wuhan in China's Hubei Province. On January 7, 2020, the causative agent was identified as a new coronavirus (2019-nCoV), and the disease was later named as COVID-19 by the WHO. The virus spread extensively in the Wuhan region of China and has gained entry to over 210 countries and territories. Though experts suspected that the virus is transmitted from animals to humans, there are mixed reports on the origin of the virus. There are no treatment options available for the virus as such, limited to the use of anti-HIV drugs and/or other antivirals such as Remdesivir and Galidesivir. For the containment of the virus, it is recommended to quarantine the infected and to follow good hygiene practices. The virus has had a significant socio-economic impact globally. Economically, China is likely to experience a greater setback than other countries from the pandemic due to added trade war pressure, which have been discussed in this paper.
has issue date	2020-05-28(xsd:dateTime)
bibo:doi	10.3389/fpubh.2020.00216
bibo:pmid	32574299
has license	cc-by
sha1sum (hex)	e75b01242ba3766cf1c6cbc8b0f388f5138c9872
schema:url	https://doi.org/10.3389/fpubh.2020.00216
resource representing a document's title	COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
has PubMed Central identifier	PMC7270802
has PubMed identifier	32574299
schema:publication	Front Public Health
resource representing a document's body	covid:e75b01242ba3766cf1c6cbc8b0f388f5138c9872#body_text
is schema:about of	named entity 'Coronavirus' named entity 'Biochemical' named entity 'Aerosol' named entity 'infection' named entity 'ACE2 receptor' named entity 'MERS' named entity 'lungs' named entity 'viral proteins' named entity 'MERS' named entity 'SARS' named entity 'virus shedding' named entity 'phagocytic' named entity 'COVID' named entity 'SARS' named entity 'SARS outbreak' named entity 'lung' named entity 'MERS' named entity 'stomach' named entity 'Favipiravir' named entity 'China' named entity 'China' named entity 'RNA' named entity 'letter to the editor' named entity 'detergent' named entity 'antibodies' named entity 'CDC' named entity 'virus' named entity 'quarantine' named entity 'SARS-CoV-2' named entity 'mental health' named entity 'coronavirus' named entity 'virus' named entity 'South Korea' named entity 'case fatality rates' named entity 'WHO' named entity 'SARS-CoV-2' named entity 'family of viruses' named entity 'virus' named entity 'family of viruses' named entity 'diseases in humans' named entity 'isopropyl alcohol' named entity 'infection' named entity 'China' named entity 'Diamond Princess' named entity 'Singapore' named entity 'viral genome' named entity 'placebo' named entity 'COVID-19' named entity 'WHO' named entity 'virus' named entity 'SARS' named entity 'Chloroquine' named entity 'adverse effects' named entity 'Ribavirin' named entity 'comorbidities' named entity '210 countries and territories' named entity 'Remdesivir' named entity 'hypertension' named entity 'placebo' named entity 'Starbucks' named entity 'asymptomatic' named entity 'pregnant women' named entity 'corona virus' named entity 'COVID-19' named entity 'India' named entity 'India' named entity 'RNA' named entity 'C-reactive protein' named entity 'antibodies' named entity 'viral RNA' named entity 'long-term' named entity 'infection' named entity 'virus' named entity 'Ebola Virus Disease' named entity 'Italy' named entity 'SARS-CoV-2' named entity 'infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software